The CAREGENE study: Genetic variants of the endothelium and aerobic power in patients with coronary artery disease

Acta Cardiologica

Volumn 66, Issue 4, 2011, Pages 404-414

  Onkelinx, Steven ^a   Cornelissen, Veronique ^a   Defoor, Johan ^a   Matthijs, Gert ^b   Thomaes, Tom ^a   Coeckelberghs, Ellen ^a   Buys, Roselien ^a   Schepers, Dirk ^a   Fagard, Robert ^a   Vanhees, Luc ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cardiac rehabilitation; Coronary disease; Endothelium; Exercise; Oxygen uptake; Polymorphism

Indexed keywords

CATALASE; CYSTEINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THREONINE; VASCULOTROPIN; GLUTATHIONE PEROXIDASE; NOS3 PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SUPEROXIDE DISMUTASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AEROBIC CAPACITY; ARTICLE; ASSAY; BICYCLE TESTING; CAUCASIAN; CLINICAL ASSESSMENT TOOL; CORONARY ARTERY DISEASE; ENDOTHELIUM; EXHAUSTION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; TRAINING; EXERCISE TOLERANCE; GENETICS; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

CATALASE; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN CONSUMPTION; POLYMORPHISM, GENETIC; PPAR ALPHA; SUPEROXIDE DISMUTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051954187     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.4.2126586     Document Type: Article

References (31)

1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18: 1231-1248.
2. Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in patients with coronary artery disease. J Am Coll Cardiol 1994; 23: 358-363.
3. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001; 345: 892-902.
4. Fagard RH. Physical exercise and coronary artery disease. Acta Cardiol 2002; 57: 91-100.
5. Wilmore JH, Green JS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C. Relationship of changes in maximal and submaximal aerobic fitness to changes in cardiovascular disease and non-insulin-dependent diabetes mellitus risk factors with endurance training: the HERITAGE Family Study. Metabolism 2001; 50: 1255-1263.
6. Vanhees L, Fagard R, Thijs L, Amery A. Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol 1995; 76: 1014-1019.
7. Vanhees L, Stevens A, Schepers D, Defoor J, Rademakers F, Fagard R. Determinants of the effects of physical training and of the complications requiring resuscitation during exercise in patients with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004; 11: 304-312.
8. Lesage R, Simoneau JA, Jobin J, Leblanc J, Bouchard C. Familial resemblance in maximal heart rate, blood lactate and aerobic power. Hum Hered 1985; 35: 182-189.
9. Prud'homme D, Bouchard C, Leblanc C, Landry F, Fontaine E. Sensitivity of maximal aerobic power to training is genotype-dependent. Med Sci Sports Exerc 1984; 16: 489-493.
10. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W, Hintze TH. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc 1995; 27: 1125-1134.
11. Kojda G, Cheng YC, Burchfield J, Harrison DG. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 2001; 103: 2839-2844.
12. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004; 44: 381-386.
13. Defoor J, Martens K, Zielinska D, Matthijs G, Van NH, Schepers D, Fagard R, Vanhees L. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J 2006; 27: 808-816.
14. Duncan GE, Howley ET, Johnson BN. Applicability of VO2max criteria: discontinuous versus continuous protocols. Med Sci Sports Exerc 1997; 29: 273-278.
15. Hall JG, Eis PS, Law SM, Reynaldo LP, Prudent JR, Marshall DJ, Allawi HT, Mast AL, Dahlberg JE, Kwiatkowski RW, de Arruda M, Neri BP, Lyamichev VI. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci U S A 2000; 97: 8272-8277.
16. Hessner MJ, Budish MA, Friedman KD. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 2000; 46(8 Pt 1): 1051-1056.
17. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
18. Calnek DS, Mazzella L, Roser S, Roman J, Hart CM. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 52-57.
19. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152-3158.
20. Data SA, Roltsch MH, Hand B, Ferrell RE, Park JJ, Brown MD. ENOS T-786C genotype, physical activity, and peak forearm blood flow in females. Med Sci Sports Exerc 2003; 35: 1991-1997.
21. Erbs S, Baither Y, Linke A, Adams V, Shu Y, Lenk K, Gielen S, Dilz R, Schuler G, Hambrecht R. Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction. Arterioscler Thromb Vasc Biol 2003; 23: 1814-1819.
22. Sofowora G, Dishy V, Xie HG, Imamura H, Nishimi Y, Morales CR, Morrow JD, Kim RB, Stein CM, Wood AJ. In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism. Pharmacogenetics 2001; 11: 809-814.
23. Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder RE. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens 2000; 18: 1767-1773.
24. Ennezat PV, Malendowicz SL, Testa M, Colombo PC, Cohen-Solal A, Evans T, LeJemtel TH. Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes. J Am Coll Cardiol 2001; 38: 194-198.
25. Dieterich S, Bieligk U, Beulich K, Hasenfuss G, Prestle J. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 2000; 101: 33-39.
26. Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505.
27. Christiansen L, Petersen HC, Bathum L, Frederiksen H, McGue M, Christensen K. The catalase -262C/T promoter polymorphism and aging phenotypes. J Gerontol A Biol Sci Med Sci 2004; 59: B886-B889.
28. Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA. PPARalpha gene variation and physical performance in Russian athletes. Eur J Appl Physiol 2006; 97: 103-108.
29. Biselli PM, Guerzoni AR, de Godoy MF, Pavarino-Bertelli EC, Goloni-Bertollo EM. Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 2008; 23: 371-375.
30. Gustafsson T, Bodin K, Sylven C, Gordon A, Tyni-Lenne R, Jansson E. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest 2001; 31: 362-366.
31. Metzger IF, Sertorio JT, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 2007; 43: 987-992.